Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BRIAN BERNHARDT

Allopathic & Osteopathic Physicians Anesthesiology

NPI
1255594909
CMS profile
997552
Location
SHREVEPORT, LA

General Payments · PY2018–2024

$5,078.74

  • Reported across 126 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$676.75

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $676.75 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Nevro Corp. $210.09 6
BOSTON SCIENTIFIC CORPORATION $185.34 3
Averitas Pharma Inc. $144.85 2
Curonix LLC $97.95 1
Saluda Medical Americas, Inc. $26.06 1
SPR Therapeutics, Inc $12.46 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,352.72 50
PY2019 $905.95 30
PY2020 $151.20 5
PY2021 $168.97 5
PY2022 $647.48 8
PY2023 $1,175.67 14
PY2024 $676.75 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Averitas Pharma Inc. $19.86 02/08/2024 Food and Beverage Undisputed 01/23/2026 1133418326 CMS
Averitas Pharma Inc. $124.99 07/22/2024 Food and Beverage Undisputed 01/23/2026 1133418330 CMS
Boston Scientific Corporation $15.26 05/23/2024 Food and Beverage Undisputed 01/23/2026 1092589067 CMS
Boston Scientific Corporation $36.15 07/15/2024 Food and Beverage Undisputed 01/23/2026 1092589069 CMS
Boston Scientific Corporation $133.93 10/15/2024 Food and Beverage Undisputed 01/23/2026 1092589071 CMS
Curonix LLC $97.95 04/05/2024 Food and Beverage Undisputed 01/23/2026 1132905392 CMS
Nevro Corp. $22.24 01/25/2024 Food and Beverage Undisputed 01/23/2026 1130771176 CMS
Nevro Corp. $17.07 06/25/2024 Food and Beverage Undisputed 01/23/2026 1130771138 CMS
Nevro Corp. $11.89 09/21/2024 Food and Beverage Undisputed 01/23/2026 1130771170 CMS
Nevro Corp. $108.36 09/21/2024 Food and Beverage Undisputed 01/23/2026 1130771172 CMS
Nevro Corp. $27.72 09/22/2024 Food and Beverage Undisputed 01/23/2026 1130771174 CMS
Nevro Corp. $22.81 10/14/2024 Food and Beverage Undisputed 01/23/2026 1130771178 CMS
Saluda Medical Americas, Inc. $26.06 03/07/2024 Food and Beverage Undisputed 01/23/2026 1081873346 CMS
SPR Therapeutics, Inc $12.46 04/10/2024 Food and Beverage Undisputed 01/23/2026 1104929523 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.